What is the Impact Factor of Revista Cubana de Farmacia?

The journal Revista Cubana de Farmacia is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Revista Cubana de Farmacia indexed in Web of Science or Scopus?

Yes, Revista Cubana de Farmacia is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.145 (Q4) and an H-index of 10.

Who publishes Revista Cubana de Farmacia and what is the Article Processing Charge (APC)?

Revista Cubana de Farmacia is published by Editorial Ciencias Medicas. The estimated Article Processing Charge (APC) is approximately $2,311 USD, subject to institutional waivers and corresponding author affiliations.

WoS SCIE Q1Scopus Q4SCImago #25,769Subscription

Revista Cubana de Farmacia

Identifier (ISSN):0034-7515(Print)/1561-2988(Online)

•

Publisher:Editorial Ciencias Medicas

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Revista Cubana de Farmacia

WoS Q1

Annual Impact Factor Metric

Current (2025):0

Scopus SJR & RankScopus Q4

0.145

#25,769

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

10 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessSubscription

34articles/year

0% Gold OA•0% Original Research

Aims & Scope

La Revista Cubana de Farmacia tiene la misión de publicar artículos sobre farmacología, ciencias afines y farmacopea cubana, que tratan sobre la aplicación de riquezas de nuestra flora en la industria farmacéutica y de la fauna de nuestros mares y su posible empleo en la elaboración de medicamentos. Se distribuye directamente por el editor a los suscriptores en formato impreso (ISSN 0034-7515). Está dirigida a profesionales y técnicos en el campo de la estomatología, su administración de salud, y especialidades afines. Recibe contribuciones en idioma español, inglés y portugués sin distinción en el país de procedencia.

Topics Covered (Recognized by AI)

Medicine46.4%Chemistry35%Philosophy34.6%Art32.8%Humanities31.6%Biology27.3%

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics Pharmaceutical Science

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

13 year

2025Latest

IF0

Articles / Year—

Total Citations—

2021

IF—

Articles / Year34

Total Citations3

2020

IF—

Articles / Year35

Total Citations11

2019

IF—

Articles / Year30

Total Citations21

2018

IF—

Articles / Year15

Total Citations5

Year	Impact Factor	Articles / Year	Total Citations
2025	0	—	—
2021	—	34	3
2020	—	35	11
2019	—	30	21
2018	—	15	5
2017	—	15	8
2016	—	56	32
2015	—	83	82
2014	—	28	13
2013	—	19	11
2012	—	23	13
2011	—	35	57
2010	—	34	31

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #25,769Scopus Q4SCImago Profile

Scopus Coverage:1980-1991, 1996-2000, 2002, 2004-2025

•

Scopus Broad Areas:Health ProfessionsPharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q4

0.145

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4

Citations / Doc (2 years)

0.06

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,311 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations11

3-Year Documents106

Citable Documents104

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate56.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ4

PharmacologyQ4

PharmacyQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Revista Cubana de Farmacia (ISSN: 0034-7515) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Editorial Ciencias Medicas in Cuba. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.145 (Q4), an H-index of 10.

The journal enforces rigorous peer evaluation with an annual output of approximately 34 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,311 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.